Lack of an association between interleukin-6 gene promoter polymorphisms (-174G/C, -572G/C) and ischemic heart disease and/or ischemic stroke: A meta-analysis

Human Immunology

Volumn 72, Issue 8, 2011, Pages 641-651

  Ma, Ying ^a,b   Tang, Ren Kuan ^c   Yang, Xu ^a   Peng, Guo Guang ^a   Liu, Yun ^b   Wang, Xiao Ming ^b   Wu, Bi Hua ^b   Yu, Ju Ming ^b  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Interleukin 6; Ischemic heart disease; Ischemic stroke; Meta analysis; Single nucleotide polymorphism

Indexed keywords

INTERLEUKIN 6;

ADULT; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DOMINANT GENE; ETHNICITY; EUROPE; FEMALE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; META ANALYSIS (TOPIC); PRIORITY JOURNAL; PROMOTER REGION; PUBLISHING; RANDOMIZED CONTROLLED TRIAL; RECESSIVE GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STABLE ANGINA PECTORIS; SYSTEMATIC REVIEW; UNSTABLE ANGINA PECTORIS;

AGE FACTORS; ETHNIC GROUPS; GENOTYPE; HUMANS; INTERLEUKIN-6; MODELS, STATISTICAL; MYOCARDIAL ISCHEMIA; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SEX FACTORS; STROKE;

EID: 79960159518     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.03.019     Document Type: Article

References (66)

1. Heinrich P.C., Castell J.V., Andus T. Interleukin-6 and the acute phase response. Biochem J 1990, 265:621-636.
2. Papanicolaou D.A., Wilder R.L., Manolagas S.C., Chrousos G.P. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998, 128:127-137.
3. Kosmala W., Przewlocka-Kosmala M., Mazurek W. Proinflammatory cytokines and myocardial viability in patients after acute myocardial infarction. Int J Cardiol 2005, 101:449-456.
4. Beamer N.B., Coull B.M., Clark W.M., Hazel J.S., Silberger J.R. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 1995, 37:800-805.
5. Seino Y., Ikeda U., Ikeda M., Yamamoto K., Misawa Y., Hasegawa T., et al. Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. Cytokines 1994, 6:87-91.
6. Castillo J., Rodríguez I. Biochemical changes and inflammatory response as markers for brain ischaemia: molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovasc Dis 2004, 17(suppl 1):7-18.
7. Tso A.R., Merino J.G., Warach S. Interleukin-6 174G/C polymorphism and ischemic stroke: a systematic review. Stroke 2007, 38:3070-3075.
8. Ridker P.M., Rifai N., Stampfer M.J., Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000, 101:1767-1772.
9. Georges J.L., Loukaci V., Poirier O., Evans A., Luc G., Arveiler D., et al. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Témoin de l'infarctus du Myocarde. J Mol Med 2001, 79:300-305.
10. Tong Y., Wang Z., Geng Y., Liu J., Zhang R., Lin Q., et al. The association of functional polymorphisms of IL-6 gene promoter with ischemic stroke: analysis in two Chinese populations. Biochem Biophys Res Commun 2010, 391:481-485.
11. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998, 102:1369-1376.
12. Terry C.F., Loukaci V., Green F.R. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000, 275:18138-18144.
13. Smith A.J., D'Aiuto F., Palmen J., Cooper J.A., Samuel J., Thompson S., et al. Association of serum interleukin-6 concentration with a functional IL6 -6331T>C polymorphism. Clin Chem 2008, 54:841-850.
14. Park S., Youn J.C., Shin D.J., Park C.M., Kim J.S., Ko Y.G., et al. Genetic polymorphism in the pregnancy-associated plasma protein-A associated with acute myocardial infarction. Coron Artery Dis 2007, 18:417-422.
15. Yamada Y., Metoki N., Yoshida H., Satoh K., Ichihara S., Kato K., et al. Genetic risk for ischemic and hemorrhagic stroke. Arterioscler Thromb Vasc Biol 2006, 26:1920-1925.
16. Podgoreanu M.V., White W.D., Morris R.W., Mathew J.P., Stafford-Smith M., Welsby I.J., et al. Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery. Circulation 2006, 114(1 suppl):I275-I281.
17. Kelberman D., Hawe E., Luong L.A., Mohamed-Ali V., Lundman P., Tornvall P., et al. Effect of interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study. Thromb Haemost 2004, 92:1122-1128.
18. Humphries S.E., Luong L.A., Ogg M.S., Hawe E., Miller G.J. The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 2001, 22:2243-2252.
19. Rios D.L., Cerqueira C.C., Bonfim-Silva R., Araujo L.J., Pereira J.F., Gadelha S.R., et al. Interleukin-1 beta and interleukin-6 gene polymorphism associations with angiographically assessed coronary artery disease in Brazilians. Cytokines 2010, 50:292-296.
20. Ghazouani L., Ben Hadj Khalifa S., Abboud N., Hamda K.B., Khalfallah A.B., Brahim N., et al. TNF-alpha -308G>A and IL-6 -174 G>C polymorphisms in Tunisian patients with coronary artery disease. Clin Biochem 2010, 43:1085-1089.
21. Banerjee I., Pandey U., Hasan O.M., Parihar R., Tripathi V., Ganesh S. Association between inflammatory gene polymorphisms and coronary artery disease in an Indian population. J Thromb Thrombolysis 2009, 27:88-94.
22. Sarecka B., Zak I., Krauze J. Synergistic effects of the polymorphisms in the PAI-1 and IL-6 genes with smoking in determining their associated risk with coronary artery disease. Clin Biochem 2008, 41:467-473.
23. Nauck M., Winkelmann B.R., Hoffmann M.M., Bohm B.O., Wieland H., Marz W. The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction. J Mol Med 2002, 80:507-513.
24. Basso F., Lowe G.D., Rumley A., McMahon A.D., Humphries S.E. Interleukin-6 -174G>C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). Arterioscler Thromb Vasc Biol 2002, 22:599-604.
25. Manginas A., Tsiavou A., Chaidaroglou A., Giamouzis G., Degiannis D., Panagiotakos D., et al. Inflammatory cytokine gene variants in coronary artery disease patients in Greece. Coron Artery Dis 2008, 19:575-582.
26. Ozdemir O., Gundogdu F., Karakelleoglu S., Sevimli S., Pirim I., Acikel M., et al. Comparison of serum levels of inflammatory markers and allelic variant of interleukin-6 in patients with acute coronary syndrome and stable angina pectoris. Coron Artery Dis 2008, 19:15-19.
27. Berg K.K., Madsen H.O., Garred P., Wiseth R., Gunnes S., Videm V. The additive contribution from inflammatory genetic markers on the severity of cardiovascular disease. Scand J Immunol 2009, 69:36-42.
28. Kuo L.T., Yang N.I., Cherng W.J., Verma S., Hung M.J., Wang S.Y., et al. Serum interleukin-6 levels, not genotype, correlate with coronary plaque complexity. Int Heart J 2008, 49:391-402.
29. Jang Y., Kim O.Y., Hyun Y.J., Chae J.S., Koh S.J., Heo Y.M., et al. Interleukin-6-572C>G polymorphism-association with inflammatory variables in Korean men with coronary artery disease. Transl Res 2008, 151:154-161.
30. Ortlepp J.R., Krantz C., Kimmel M., von Korff A., Vesper K., Schmitz F., et al. Additive effects of the chemokine receptor 2, vitamin D receptor, interleukin-6 polymorphisms and cardiovascular risk factors on the prevalence of myocardial infarction in patients below 65 years. Int J Cardiol 2005, 105:90-95.
31. Aker S., Bantis C., Reis P., Kuhr N., Schwandt C., Grabensee B., et al. Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients. Nephrol Dial Transplant 2009, 24:2847-2851.
32. Sarecka-Hujar B., Zak I., Krauze J. Carrier-state of two or three polymorphic variants of MTHFR, IL-6 and ICAM1 genes increases the risk of coronary artery disease. Kardiol Pol 2008, 66:1269-1277.
33. Chiappelli M., Tampieri C., Tumini E., Porcellini E., Caldarera C.M., Nanni S., et al. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Int J Immunogenet 2005, 32:349-353.
34. Licastro F., Chiappelli M., Caldarera C.M., Tampieri C., Nanni S., Gallina M., et al. The concomitant presence of polymorphic alleles of interleukin-1beta, interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial infarction in elderly men. Results from a pilot study. Mech Ageing Dev 2004, 125:575-579.
35. Flex A., Gaetani E., Papaleo P., Straface G., Proia A.S., Pecorini G., et al. Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke 2004, 35:2270-2275.
36. Pola R., Flex A., Gaetani E., Flore R., Serricchio M., Pola P. Synergistic effect of -174 G/C polymorphism of the interleukin-6 gene promoter and 469 e/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke. Stroke 2003, 34:881-885.
37. Lalouschek W., Schillinger M., Hsieh K., Endler G., Greisenegger S., Marculescu R., et al. Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events. Clin Chem Lab Med 2006, 44:918-923.
38. Greisenegger S., Endler G., Haering D., Schillinger M., Lang W., Lalouschek W., et al. The (-174) G/C polymorphism in the interleukin-6 gene is associated with the severity of acute cerebrovascular events. Thromb Res 2003, 110:181-186.
39. Thakkinstian A., McEvoy M., Minelli C., Gibson P., Hancox B., Duffy D., et al. Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 2005, 162:201-211.
40. Camargo M.C., Mera R., Correa P., Peek R.M., Fontham E.T., Goodman K.J., et al. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15:1674-1687.
41. Bennet A.M., Prince J.A., Fei G.Z., Lyrenäs L., Huang Y., Wiman B., et al. Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction. Atherosclerosis 2003, 171:359-367.
42. Banerjee I., Gupta V., Ahmed T., Faizaan M., Agarwal P., Ganesh S. Inflammatory system gene polymorphism and the risk of stroke: a case-control study in an Indian population. Brain Res Bull 2008, 75:158-165.
43. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
44. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
45. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719-748.
46. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-186.
47. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
48. Jia X., Tian Y., Wang Y., Deng X., Dong Z., Scafa N., et al. Association between the interleukin-6 gene -572G/C and -597G/A polymorphisms and coronary heart disease in the Han Chinese. Med Sci Monit 2010, 16:CR103-CR108.
49. Chamorro A., Revilla M., Obach V., Vargas M., Planas A.M. The -174G/C polymorphism of the interleukin 6 gene is a hallmark of lacunar stroke and not other ischemic stroke phenotypes. Cerebrovasc Dis 2005, 19:91-95.
50. Balding J., Livingstone W.J., Pittock S.J., Mynett-Johnson L., Ahern T., Hodgson A., et al. The IL-6 G-174C polymorphism may be associated with ischaemic stroke in patients without a history of hypertension. Ir J Med Sci 2004, 173:200-203.
51. Lieb W., Pavlik R., Erdmann J., Mayer B., Holmer S.R., Fischer M., et al. No association of interleukin-6 gene polymorphism (-174 G/C) with myocardial infarction or traditional cardiovascular risk factors. Int J Cardiol 2004, 97:205-212.
52. Sekuri C., Cam F.S., Sagcan A., Ercan E., Tengiz I., Alioglu E., et al. No association of interleukin-6 gene polymorphism (-174 G/C) with premature coronary artery disease in a Turkish cohort. Coron Artery Dis 2007, 18:333-337.
53. Rosner S.A., Ridker P.M., Zee R.Y., Cook N.R. Interaction between inflammation-related gene polymorphisms and cigarette smoking on the risk of myocardial infarction in the Physician's Health Study. Hum Genet 2005, 118:287-294.
54. Weger M., Steinbrugger I., Haas A., Marz W., El-Shabrawi Y., Weger W., et al. Role of the interleukin-6 -174 G>C gene polymorphism in retinal artery occlusion. Stroke 2005, 36:249-252.
55. Revilla M., Obach V., Cervera A., Dávalos A., Castillo J., Chamorro A. A -174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction. Neurosci Lett 2002, 324:29-32.
56. Densem C.G., Ray M., Hutchinson I.V., Yonan N., Brooks N.H. Interleukin-6 polymorphism: a genetic risk factor for cardiac transplant related coronary vasculopathy?. J Heart Lung Transplant 2005, 24:559-565.
57. Valdes A.M., Arden N.K., Tamm A., Kisand K., Doherty S., Pola E., et al. A meta-analysis of interleukin-6 promoter polymorphisms on risk of hip and knee osteoarthritis. Osteoarthritis Cartilage 2010, 18:699-704.
58. Sie M.P., Sayed-Tabatabaei F.A., Oei H.H., Uitterlinden A.G., Pols H.A., Hofman A., et al. Interleukin 6 -174 g/c promoter polymorphism and risk of coronary heart disease: results from the Rotterdam study and a meta-analysis. Arterioscler Thromb Vasc Biol 2006, 26:212-217.
59. Burzotta F., Iacoviello L., Di Castelnuovo A., Glieca F., Luciani N., Zamparelli R., et al. Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am J Cardiol 2001, 88:1125-1128.
60. Hulkkonen J., Pertovaara M., Antonen J., Pasternack A., Hurme M. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren's syndrome and correlate with the clinical manifestations of the disease. Rheumatol Oxf 2001, 40:656-661.
61. Jerrard-Dunne P., Sitzer M., Risley P., Steckel D.A., Buehler A., von Kegler S., et al. Interleukin-6 promoter polymorphism modulates the effects of heavy alcohol consumption on early carotid artery atherosclerosis: the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2003, 34:402-407.
62. Jones K.G., Brull D.J., Brown L.C., Sian M., Greenhalgh R.M., Humphries S.E., et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 2001, 103:2260-2265.
63. Mälarstig A., Wallentin L., Siegbahn A. Genetic variation in the interleukin-6 gene in relation to risk and outcomes in acute coronary syndrome. Thromb Res 2007, 119:467-473.
64. Huedo-Medina T.B., Sanchez-Meca J., Marin-Martinez F., Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index?. Psychol Methods 2006, 11:193-206.
65. Karahan Z.C., Deda G., Sipahi T., Elhan A.H., Akar N. TNF-alpha -308G/A and IL-6 -174 G/C polymorphisms in the Turkish pediatric stroke patients. Thromb Res 2005, 115:393-398.
66. Myśliwska J., Wieckiewicz J., Hak L., Siebert J., Rogowski J., Szyndler K., et al. Interleukin 6 polymorphism corresponds to the number of severely stenosed coronary arteries. Eur Cytokine Netw 2006, 17:181-188.